Breaking News
Get 45% Off 0
Is it finally time to sell Nvidia ahead of earnings?
Read More

Stock Markets Analysis & Opinion

Contribute
Zacks Investment Research
Salesforce (CRM) Q4 Earnings Beat Estimates, Revenues Up Y/Y By Zacks Investment Research - Mar 01, 2018

Salesforce.com Inc. (NYSE:CRM) reported fourth-quarter fiscal 2018 non-GAAP earnings of 35 cents per share, which beat the Zacks Consensus Estimate by a couple of cents and came ahead of the guided...

Zacks Investment Research
Universal Health (UHS) Q4 Earnings, Revenues Beat Estimates By Zacks Investment Research - Mar 01, 2018

Universal Health Services Inc. (NYSE:UHS) reported fourth-quarter 2017 adjusted earnings of $2.00 per share that surpassed the Zacks Consensus Estimate of $1.84 by 8.7%. Earnings also grew 11% year...

Zacks Investment Research
Is A Beat In The Cards For Celldex (CLDX) In Q4 Earnings? By Zacks Investment Research - Mar 01, 2018

We expect Celldex Therapeutics, Inc. (NASDAQ:CLDX) to beat expectations when it reports fourth-quarter 2017 results next month. Its performance has been encouraging as it beat estimates in three of...

Zacks Investment Research
Biotech ETFs Head To Head: XBI Vs. IBB. By Zacks Investment Research - Mar 01, 2018

The biotech sector has been attracting a lot of investor attention lately. This sector is expected to continue benefiting from increased M&A activities, new drug approvals, better R&D and...

Zacks Investment Research
Tech Roundup: Amazon In Healthcare, Google Pay Launches By Zacks Investment Research - Mar 01, 2018

Amazon (NASDAQ:AMZN) selling over the counter medications and Alphabet (NASDAQ:GOOGL) rebranding and enhancing Android Pay as Google Pay were the top stories from last week.The Amazon Drug...

Zacks Investment Research
Is Costco (COST) Set To Beat Earnings Estimates? By Zacks Investment Research - Mar 01, 2018

Multibillion-dollar big-box stores might prove to be among the only retailers that can compete against Amazon (NASDAQ:AMZN) as it slowly undercuts smaller online sellers and brick-and-mortar...

Zacks Investment Research
Is Urban Outfitters (URBN) Poised To Beat Q4 Earnings? By Zacks Investment Research - Mar 01, 2018

The shifting retail landscape has been written about ad nauseam, and for good reason. Brick-and-mortar businesses continue to struggle and e-commerce continues to infiltrate more and more retail...

Zacks Investment Research
Analog Devices (ADI) Q1 Earnings Beat, Guidance Impressive By Zacks Investment Research - Mar 01, 2018

Analog Devices Inc. (NASDAQ:ADI) reported first-quarter fiscal 2018 adjusted earnings of $1.42 per share, beating the Zacks Consensus Estimate by 13 cents. Although the bottom line surged 51.1% year...

Zacks Investment Research
Best Buy (BBY) Rallies On Q4 Earnings Beat, Guides For FY19 By Zacks Investment Research - Mar 01, 2018

Best Buy Company, Inc. (NYSE:BBY) returned to positive earnings trend in fourth-quarter fiscal 2018 after reporting a miss in the preceding quarter. With this, the company has delivered positive...

Zacks Investment Research
TEGNA (TGNA) Tops Q4 Earnings Estimates, Issues 1Q18 View By Zacks Investment Research - Mar 01, 2018

TEGNA (NYSE:TGNA) reported impressive financial results in the fourth quarter of 2017, wherein both the top line and the bottom line outpaced the Zacks Consensus Estimate.Currently, TEGNA is a Zacks...

Zacks Investment Research
NRG Energy (NRG) Q4 Sales Beat Estimates, 2017 Loss Widens By Zacks Investment Research - Mar 01, 2018

NRG Energy, Inc. (NYSE:NRG) reported loss of $4.30 per share in the fourth quarter of 2017, much wider than the year-ago loss of $2.51.RevenuesNRG Energy posted revenues of $2,458 million in the...

Zacks Investment Research
Kohl's (KSS) Q4 Earnings & Sales Increase Y/Y, Stock Gains By Zacks Investment Research - Mar 01, 2018

Kohl’s Corporation (NYSE:KSS) posted fourth-quarter fiscal 2017 results, wherein both the top and the bottom line improved year over year and topped the Zacks Consensus Estimate. While this...

Edison
Pluristem Therapeutics: New Avenues Of Study   By Edison - Mar 01, 2018

Pluristem (NASDAQ:PSTI) continues to advance its PLX technology platform. In a recent paper it investigated the application of these cells for their ability to inhibit tumor growth; it was found that...

Zacks Investment Research
Buffett Backs Great Rotation: 4 Value Stocks & ETFs To Buy By Zacks Investment Research - Mar 01, 2018

The Oracle (NYSE:ORCL) of Omaha recently reaffirmed his liking for the concept of great rotation — a shift to equities from bonds. Warren Buffett believes long-term investors should go for...

Continue with Apple
Continue with Google
or
Sign up with Email